Ikena Oncology Inc.

NASDAQ: IKNA · Real-Time Price · USD
17.16
15.79 (1152.55%)
At close: Jul 25, 2025, 3:59 PM

Ikena Oncology Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-49.23M -68.17M -68.77M -34.12M
Depreciation & Amortization
490K 1.02M 751K 544K
Stock-Based Compensation
5.29M 7.63M 7.53M 5.18M
Other Working Capital
-2.81M -18.8M -14.56M -33.39M
Other Non-Cash Items
1.42M 1.44M 1.52M 1.17M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-3.98M -21.67M -15.14M -33.03M
Operating Cash Flow
-46M -79.74M -74.11M -60.25M
Capital Expenditures
n/a -414K -1.43M -1.76M
Cash Acquisitions
n/a n/a 97.85M n/a
Purchase of Investments
-88.3M -90.05M -216.34M n/a
Sales Maturities Of Investments
60.46M 154.61M 118.48M n/a
Other Investing Acitivies
-7.07M n/a -97.85M -1.77M
Investing Cash Flow
-34.9M 64.14M -99.28M -1.76M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a -663K n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a -808K 1.09M 582K
Financial Cash Flow
n/a 75.98M 1.09M 131.74M
Net Cash Flow
-80.91M 60.38M -172.3M 69.73M
Free Cash Flow
-46M -80.16M -75.54M -62.01M